Faradin Mirkhalaf

Director of R&D
Nanomedpharma Limited

Bilateral Meetings

  • Thursday (1:30pm – 6:00pm)
  • Friday (9:00am – 12:00pm)
Description

NanoMedPharma (NMP) is a specialised multi-disciplinary company with a clear mission of contributing towards improving patients’ quality of life. The activities of NMP are cross-disciplinary incorporating science and technology to provide the best in class nanoscience by means of production, modification and application of nanoparticles in medicinal products for a better outcome in diagnosis, treatment and monitoring of various diseased conditions.The company has established excellent links with a number of healthcare industries as well as research-based and teaching academic institutions at national and international levels. NMP aims at developing novel nanomaterials for the applications in medicine and healthcare including medical sensors and diagnosis, pharmaceuticals, drug delivery and antibacterial surfaces. We invite all types of partnerships at the following fields: 

  • Nanomaterials & Nanomedicine
  • Medical Sensors and POCT devices
  • Diagnostic Assays
  • Modified Surfaces
  • Drug Delivery
Organization Type Company
CountryUnited Kingdom
CityDaresbury, B76, Sci-Tech Daresbury Google map
Request

Nanomaterial Coatings as antibacterials

This is a novel technology for antimicrobial wound dressings. The project has passed proof of market and proof of concept with funding support from the Innovate UK. The project is now under the prototyping and commercialisation stage. We are looking for partners with experience in coating, polymer and textile technology, biomedical engineering and / or medical devices, especially wound dressings, to help us scale-up manufacture of this technology and assess its commercial and technical feasibility.

Keywords: Scale Up manufactureWound DressingsAntimicrobial coatingsMedical devicesNanomaterial coatings
Cooperation Requested
  1. Investment/Financing
  2. Manufacturing agreement
  3. Outsourcing co-operation
  4. Technical co-operation
  5. License agreement